Dr. Naoya Yamazaki Dermatologic Oncology


Mubatsiri - Dermatologic Oncology, Chiitiko:

Book Appointment

Nezve Chiremba

Dr. Naoya Yamazaki ndemumwe wenyanzvi dzegomarara reganda dzakanakisa muTokyo, Japan.

Dr. Naoya Yamazaki ane hukama neNational Cancer Center Hospital, Japan.

chipatara

National Cancer Center, Japan

Nyanzvi

  • Dermatologic Oncology

Maitiro Akaitwa

  • Dermatologic Oncology
  • Melanoma

Tsvagiridzo & Mabhuku

  1. Adjuvant Nivolumab Maringe neIpilimumab muRinochengetedzwa Chikamu chechitatu III kana IV Melanoma
  2. Encorafenib Plus Binimetinib Versus Vemurafenib kana Encorafenib muvarwere vane BRAF-mutant Melanoma (COLUMBUS): Multicentre, Open-Label, Randomized Phase 3 Trial
  3. Kupona Kwapose Muvarwere NeBRAF-mutant Melanoma Kugamuchira Encorafenib Plus Binimetinib Versus Vemurafenib kana Encorafenib (COLUMBUS): Multicentre, Open-Label, Randomized, Phase 3 Trial

  4. Targeted Therapy uye Immunotherapy yeMelanoma muJapan

  5. Yazvino YAP1-MAML2 uye YAP1-NUTM1 Fusions muPoroma uye Porocarcinoma

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

×
Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa